FDA approves test to help screen for risk of opioid use disorder
The U.S. FDA approved a novel tool that uses genetic testing to help assess whether certain people are at risk of developing opioid use disorder.
Stay updated with breaking news from Katherine Keyes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The U.S. FDA approved a novel tool that uses genetic testing to help assess whether certain people are at risk of developing opioid use disorder.
Today, the U.S. Food and Drug Administration approved the first test that uses DNA in assessing whether certain individuals may have an elevated risk of developing opioid use disorder (OUD).
The U.S. FDA approved a novel tool that uses genetic testing to help assess whether certain people are at risk of developing opioid use disorder.
The U.S. FDA approved a novel tool that uses genetic testing to help assess whether certain people are at risk of developing opioid use disorder.
The U.S. FDA approved a novel tool that uses genetic testing to help assess whether certain people are at risk of developing opioid use disorder.